Rifamycin use and gut microbial antibiotic resistance genes in cirrhosis: Results from a double-blind, placebo-controlled clinical trial

There was a tendency towards reduced vancomycin resistance and ARG reduction after rifamycin exposure. Registration: NCT04082780 www.clinicaltrials.gov.